CIDRAP news story
Active TB cases cost low- and middle-income countries (LMICs) with high TB burdens $3.5 billion more in current annual and future lost earnings and medical expenses than HIV, yet TB receives substantially less funding, researchers in Peru and the United States write in a new study published in BMJ Global Health.
The researchers used a model to estimate the economic costs of TB and HIV to households and the economy, including factors such as the effects of parental disability or death on children’s future earnings, in 25 LMICs. The analysis was based on data from sources such as the World Health Organization Global TB Report, the Institute for Health Metrics and Evaluation’s Global Burden of Disease dataset, and Demographic Household Surveys.
Read the full news story here.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #15, 17 May 2026).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and the European AIDS Treatment Group (EATG). Subscribe to the newsletter here.
Source : CIDRAP
Related HIV and Co-Infections News
-
New JIAS viewpoint for International Day Against Homophobia, Biphobia and Transphobia
-
HIV i-Base: England’s HIV Action Plan: on target for HIV 2030 goals on preventable deaths but not for diagnoses: some key populations not included
-
Barcelona Institute for Global Health: Expanded TB screening does not speed up treatment initiation or improve survival in hospitalised patients with HIV
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.